|
Volumn 427, Issue 2, 2001, Pages 105-114
|
Recombinant Semliki Forest virus for over-expression and pharmacological characterisation of the histamine H2 receptor in mammalian cells
|
Author keywords
125I APT; cAMP determination; Cimetidine; COS 7 cell; Histamine; Histamine H2 receptor; Ranitidine; Semliki Forest virus
|
Indexed keywords
BURIMAMIDE;
CIMETIDINE;
G PROTEIN COUPLED RECEPTOR;
HISTAMINE;
HISTAMINE H2 RECEPTOR;
HISTAMINE H2 RECEPTOR ANTAGONIST;
RANITIDINE;
VIRUS VECTOR;
ANIMAL CELL;
ARTICLE;
BACULOVIRUS;
CERCOPITHECIDAE;
CONTROLLED STUDY;
GENE EXPRESSION;
GENE OVEREXPRESSION;
HOST CELL;
KIDNEY CELL;
MAMMAL CELL;
MUTATION;
NONHUMAN;
ONSET AGE;
PRIORITY JOURNAL;
PROTEIN BINDING;
RAT;
SEMLIKI FOREST ALPHAVIRUS;
VIRUS EXPRESSION;
VIRUS INFECTION;
ANIMALS;
BINDING, COMPETITIVE;
CELL LINE;
CIMETIDINE;
COS CELLS;
CYCLIC AMP;
DOSE-RESPONSE RELATIONSHIP, DRUG;
GENE EXPRESSION REGULATION;
GENETIC VECTORS;
GUANIDINES;
HISTAMINE;
IODINE RADIOISOTOPES;
MUTATION;
RADIOLIGAND ASSAY;
RANITIDINE;
RATS;
RECEPTORS, HISTAMINE H2;
RECOMBINANT FUSION PROTEINS;
SEMLIKI FOREST VIRUS;
TIME FACTORS;
TRANSFECTION;
|
EID: 0035860530
PISSN: 00142999
EISSN: None
Source Type: Journal
DOI: 10.1016/S0014-2999(01)01264-X Document Type: Article |
Times cited : (18)
|
References (55)
|